Feasibility and Preliminary Efficacy of a Child Life-Based Breathing Exercise Program for Children Recovering From Severe Pneumonia: A Pilot Randomized Controlled Trial
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
The goal of this pilot randomized controlled trial is to evaluate the feasibility and preliminary efficacy of a child life-based breathing exercise program for children recovering from severe pneumonia. The main questions it aims to answer are:
- Is the child life-based breathing exercise program feasible for hospitalized children recovering from severe pneumonia?
- Can the program improve caregiver satisfaction and promote recovery in children with severe pneumonia? Researchers will compare a child life-based breathing exercise program combined with routine health education with routine health education alone to determine whether the intervention improves rehabilitation outcomes. Participants will:
- Receive either routine health education alone or routine health education combined with the child life-based breathing exercise program
- Participate in breathing exercise training during hospitalization
- Complete assessments of caregiver satisfaction and clinical recovery outcomes, including improvement in chest imaging findings and time to resolution of symptoms such as cough, fever, and dyspnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 12, 2026
CompletedFirst Posted
Study publicly available on registry
May 18, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
Study Completion
Last participant's last visit for all outcomes
June 1, 2027
May 18, 2026
May 1, 2026
2 months
May 12, 2026
May 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Caregiver Satisfaction
Caregiver satisfaction will be assessed 1 day before discharge using a 5-point Likert scale.
1 day before discharge
Secondary Outcomes (3)
The resolution times of major symptoms and signs
Periprocedural
Improvement in chest imaging findings
Periprocedural
Completion rate
within 10 minutes after intervention
Study Arms (2)
control group
ACTIVE COMPARATORIn control group, participants received routine health education.
intervention group
EXPERIMENTALIn addition to routine health education, participants in the intervention group received a one-to-one respiratory training program based on a child life approach, delivered by the researcher.
Interventions
In addition to routine health education, participants in the intervention group received a one-to-one respiratory training program based on a child life approach, delivered by the researcher.
(1) information on common causes, typical symptoms, disease stages, and risk factors of severe pneumonia; (2) basic knowledge regarding commonly used treatments, such as anti-infective therapy, oxygen therapy, and nebulization, as well as home observation strategies; (3) dietary guidance emphasizing light and easily digestible foods, adequate hydration, and nutritional support while avoiding overly sweet, greasy, or cold foods; and (4) education on body temperature monitoring, recognition of abnormal respiratory symptoms, basic airway clearance care, and maintenance of appropriate indoor temperature, humidity, and ventilation.
Eligibility Criteria
You may qualify if:
- Children aged 6-18 years.
- Diagnosed with severe pneumonia and in the recovery phase.
- Written informed consent is obtained from caregivers, and assent is obtained from children when appropriate.
You may not qualify if:
- Contraindications to breathing exercise, including: (a) hemodynamic instability (e.g., bradycardia or tachycardia, arrhythmia, hypotension or hypertension); (b) open sternal incision; (c) extracorporeal membrane oxygenation (ECMO); (d) acute phase of severe wheezing or stridor; and (e) severe pulmonary hypertension.
- Communication disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2026
First Posted
May 18, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
June 1, 2027
Last Updated
May 18, 2026
Record last verified: 2026-05